Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.
Teamwork is one of the biggest motivating factors at Northfield's second largest employer, Post Consumer Brands.